PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
13-Apr-2021 Antibiotic Research UK launches £200,000 small research grants programme to tackle antibiotic resistance Antibiotic Research UK (ANTRUK)
13-Apr-2021 Newron announces AGM 2021 result Newron Pharmaceuticals SpA
13-Apr-2021 Newron announces AGM 2021 result Newron Pharmaceuticals S.p.A.
13-Apr-2021 Sanofi declares the offer for Kiadis unconditional Sanofi
13-Apr-2021 FDA Approves Xolair (omalizumab) Prefilled Syringe for Self-Injection Across All Indications Roche
13-Apr-2021 Jazz Pharmaceuticals Announces FDA Acceptance and Priority Review of Supplemental New Drug Application for Xywav™ (calcium, magnesium, potassium, and sodium oxybates) Oral Solution in Idiopathic Hypersomnia Jazz Pharmaceuticals
13-Apr-2021 Antibiotic Research UK launches £200,000 small research grants programme to tackle antibiotic resistance Sciad Newswire
13-Apr-2021 Evotec launches 'beLAB2122', translating academic innovation from leading German life science region in collaboration with Bristol Myers Squibb Evotec SE
13-Apr-2021 Dermapharm forecasts exceptionally strong growth for 2021 and confirms preliminary figures Dermapharm Holding SE
13-Apr-2021 Dermapharm forecasts exceptionally strong growth for 2021 and confirms preliminary figures Dermapharm Holding SE
12-Apr-2021 Eckert & Ziegler Receives Technetium Generator Licenses for Brazil Eckert & Ziegler Strahlen- und Medizintechnik AG
12-Apr-2021 CellGenix Appoints Daniel Spatz as Vice President Sales, Marketing & Logistics and Member of the Management Team B3C newswire
12-Apr-2021 Cellbox Solutions Announces New Headquarters B3C newswire
12-Apr-2021 Cosmo announces FDA approval of GI Genius™ intelligent endoscopy module, its revolutionary Artificial Intelligence device for lesion detection during colonoscopy Cosmo Pharmaceuticals N.V.
09-Apr-2021 Occupational Toxicology and Placing Worker Safety at the Forefront to be discussed at HPAPi Conference SMi Group
09-Apr-2021 RedHill Biopharma’s Phase 2/3 COVID-19 Study of Opaganib Passes Fourth DSMB Review with Unanimous Recommendation to Continue RedHill Biopharma
09-Apr-2021 Spermosens will be the 17th SmiLe company to launch an IPO Spermosens
09-Apr-2021 Abbott Receives CE Mark Approval for Next-Generation TriClip™ Device, Offering New Innovations for Tricuspid Heart Valve Repair Abbott
09-Apr-2021 Interim late-breaking clinical data validate not-alpha profile of THOR-707 (SAR444245), Sanofi’s novel investigational IL-2 Sanofi
09-Apr-2021 AstraZeneca accelerates early oncology pipeline across key strategic scientific platforms at AACR AstraZeneca